Sinovac vaccine | The Business Standard
Skip to main content
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
The Business Standard

Tuesday
June 03, 2025

Sign In
Subscribe
  • Epaper
  • Economy
    • Aviation
    • Banking
    • Bazaar
    • Budget
    • Industry
    • NBR
    • RMG
    • Corporates
  • Stocks
  • Analysis
  • Videos
    • TBS Today
    • TBS Stories
    • TBS World
    • News of the day
    • TBS Programs
    • Podcast
    • Editor's Pick
  • World+Biz
  • Features
    • Panorama
    • The Big Picture
    • Pursuit
    • Habitat
    • Thoughts
    • Splash
    • Mode
    • Tech
    • Explorer
    • Brands
    • In Focus
    • Book Review
    • Earth
    • Food
    • Luxury
    • Wheels
  • Subscribe
    • Epaper
    • GOVT. Ad
  • More
    • Sports
    • TBS Graduates
    • Bangladesh
    • Supplement
    • Infograph
    • Archive
    • Gallery
    • Long Read
    • Interviews
    • Offbeat
    • Magazine
    • Climate Change
    • Health
    • Cartoons
  • বাংলা
TUESDAY, JUNE 03, 2025

Sinovac vaccine

People queue to enquire about Sinovac vaccine at a clinic, during the coronavirus disease (COVID-19) outbreak in Singapore June 18, 2021. REUTERS/Chen Lin
Coronavirus chronicle

Singapore sees early rush for Sinovac vaccine

Singapore has vaccinated almost half its 5.7 million population with at least one dose of the vaccines from Pfizer-BioNTech (PFE.N), (22UAy.DE) and Moderna (MRNA.O)

A worker performs a quality check in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus vaccine, during a government-organized media tour in Beijing, China, September 24, 2020. /Reuters
Coronavirus chronicle

Sinovac vaccine effective in children

Hong Kong's Chief Executive Carrie Lam receives a dose of the Sinovac Biotech coronavirus disease (COVID-19) vaccine at a community vaccination centre in Hong Kong, China February 22, 2021. REUTERS/Tyrone Siu
Coronavirus chronicle

Hong Kong leader gets China's Sinovac vaccine to bolster public confidence

A worker performs a quality check in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (COVID-19) vaccine, during a government-organized media tour in Beijing, China, September 24, 2020. REUTERS/Thomas Peter
Coronavirus chronicle

Seven Chinese-made Covid-19 vaccines enter phase-3 clinical trials: Official

A booth displaying a coronavirus vaccine candidate from China National Biotec Group (CNBG), a unit of state-owned pharmaceutical giant China National Pharmaceutical Group (Sinopharm), is seen at the 2020 China International Fair for Trade in Services (CIFTIS), following the Covid-19 outbreak, in Beijing, China September 4, 2020. REUTERS/Tingshu Wang
Coronavirus chronicle

Pakistan approves Chinese Sinopharm Covid-19 vaccine for emergency use

Health care workers receive a dose of the Sinovac's coronavirus disease (COVID-19) vaccine, after Brazil health regulator Anvisa approved its emergency use at Hospital das Clinicas in Sao Paulo, Brazil January 17, 2021. REUTERS/Amanda Perobelli
Coronavirus chronicle

Brazil clears emergency use of Sinovac, AstraZeneca vaccines, shots begin

A worker performs a quality check in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus vaccine, during a government-organized media tour in Beijing, China, September 24, 2020. /Reuters
Coronavirus chronicle

‘Friend’ China to donate one million vaccine doses to Cambodia

Officers carry Covid-19 vaccine amid the coronavirus disease (COVID-19) pandemic in Banda Aceh, Aceh Province, Indonesia, January 12, 2021. Ampelsa/Antara Foto via REUTERS
Coronavirus chronicle

Wariness in Indonesia as Chinese Sinovac Covid-19 jabs start

A worker performs a quality check in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (COVID-19) vaccine, during a government-organized media tour in Beijing, China, September 24, 2020. REUTERS/Thomas Peter
Coronavirus chronicle

Malaysia's Pharmaniaga buys 14m doses of China's Sinovac Covid vaccine

Sinovac Covid-19 vaccine. Photo/TBS
Coronavirus chronicle

Brazil health regulator says application for Sinovac vaccine lacks information

A man works in the packaging facility of Chinese vaccine maker Sinovac Biotech, developing an experimental coronavirus disease (Covid-19) vaccine, during a government-organized media tour in Beijing, China, 24 September, 2020/Reuters
Coronavirus chronicle

Sinovac's Covid-19 vaccine induces quick immune response

Shouldn’t this be available in America? Photographer: Nicolas Bock/Bloomberg
Coronavirus chronicle

Brazil suspends Sinovac Covid-19 vaccine trial due to adverse event

Demonstrators carry a giant syringe as they protest against Sao Paulo state governor Joao Doria and China's Sinovac potential coronavirus disease (Covid-19) vaccine in Sao Paulo, Brazil, November 1, 2020/ Reuters
Coronavirus chronicle

Brazilians protest mandatory Covid-19 immunization, Chinese vaccine

  • Show More
EMAIL US
contact@tbsnews.net
FOLLOW US
WHATSAPP
+880 1847416158
The Business Standard
  • About Us
  • Contact us
  • Sitemap
  • Advertisement
  • Privacy Policy
  • Comment Policy
Copyright © 2025
The Business Standard All rights reserved
Technical Partner: RSI Lab

Contact Us

The Business Standard

Main Office -4/A, Eskaton Garden, Dhaka- 1000

Phone: +8801847 416158 - 59

Send Opinion articles to - oped.tbs@gmail.com

For advertisement- sales@tbsnews.net